Table 1.
Demographic, clinical, and nutritional characteristics according to sex
| Male n = 433 (59.7%) | Female n = 292 (40.3%) | Overall n = 725 | |
|---|---|---|---|
| Age, median (IQR) | 65.3 (57.4–71.9) | 62.2 (52.9–70.0) | 64.3 (55.9–71.0) |
| Age > 65 years, n (%) | 221 (51) | 128 (43.8) | 349 (48.1) |
| Treatment plan, n (%) | |||
| Chemotherapy only | 191 (44.1) | 157 (53.8) | 348 (48) |
| Chemotherapy and surgery | 132 (30.5) | 76 (26) | 208 (28.7) |
| Chemo‐radiotherapy and surgery | 49 (11.3) | 39 (13.4) | 88 (12.1) |
| Chemo‐radiotherapy | 38 (8.8) | 11 (3.8) | 49 (6.8) |
| Unknown | 23 (5.3) | 9 (3.0) | 32 (4.4) |
| Metastasis present, n (%) | 192 (44.3) | 134 (45.9) | 326 (45) |
| Weight change since diagnosis n (%) | |||
| Weight loss | 297 (68.6) | 190 (65.1) | 487 (67.2) |
| Weight stable | 52 (12.0) | 38 (13.0) | 90 (12.4) |
| Weight gain | 84 (19.4) | 64 (21.9) | 148 (20.4) |
| Weight loss (%) [mean (±SD)] | 6.3 (±7.3) | 7.3 (±8.5) | 6.7 (±7.8) |
| >10% weight loss in past 6 months n (%) | 75 (17.3) | 61 (20.9) | 136 (18.8) |
| BMI (kg/m2) n (%) | |||
| Underweight (BMI <18.5 kg/m2) | 10 (2.3) | 22 (7.5) | 32 (4.4) |
| Healthy weight (BMI 18.5–24.9 kg/m2) | 156 (36.0) | 134 (45.9) | 290 (40.0) |
| Overweight (BMI 25–29.9 kg/m2) | 185 (42.7) | 83 (28.4) | 268 (37.0) |
| Obese (BMI ≥30 kg/m2) | 82 (19) | 53 (18.2) | 135 (18.6) |
| BMI (kg/m2) mean (±SD) | 26.3 (±4.3) | 25.1 (±5.1) | 25.8 (±4.6) |
| Cancer cachexia n (%) | 192 (44.3) | 109 (37.3) | 301 (41.5) |
| Pre‐cachexiaa n (%) | 18 (5.7) | 12 (6.0) | 30 (5.8) |
| Sarcopeniab n (%) | 144 (35.8) | 130 (48.9) | 274 (41) |
| Myosteatosisc n (%) | 149 (40.8) | 132 (52.2) | 281 (45.5) |
BMI, body mass index; IQR, interquartile range; SD, standard deviation.
a
Pre‐cachexia assessed in n = 514 (male n = 315, female n = 199),
b
Sarcopenia measurable in n = 661 (male n = 402, female n = 266),
c
Muscle density measureable in n = 618 (male n = 365, female n = 253). All percentages given for total available.